Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

1. Gil-Núñez, A.
2. Masjuan, J.
3. Montaner, J.
4. Castellanos, M.
5. Segura, T.
6. Cardona, P.
7. Tembl, J.I.
8. Purroy, F.
9. Arenillas, J.
10. Palacio, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.NRL.2020.11.006 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•